Episode Details
Back to EpisodesLow Dose Ozempic/Semaglutide for Hormonal Weight Loss with Dr. Tyna Moore
Episode 1096
Published 1 year, 7 months ago
Description
Hey its Chalene Johnson, and today I'm chatting with Dr. Tyna Moore about the unconventional uses of semaglutide aka GLP 1 Agonists, Ozempic, Wegovy, Mounjaro, and Tirzepatide for treating cognitive decline, arthritis, brain fog, hormonal weight loss and more. Learn about weight loss peptides, low dosing and microdosing, minimizing side effects, and the importance of preserving muscle while using this game-changing drug. Don't miss out on this eye-opening discussion!
Watch this episode on YouTube on SUNDAY!
Learn More About Dr. Tyna
- Instagram: @drtyna
- Ozempic Uncovered Course:
- Podcast: The Dr. Tyna Show
- Youtube (Podcast): https://youtube.com/@drtyna
- Website: drtyna.com
Related Episodes:
- Ozempic and Addiction | Shocking New Research
- Berberine vs Ozempic | Natural Weight Loss
- Ozempic, Wegovy | Is Weight Loss As Simple As Eating Less?
Research:
- Genetic determinants of circulating GIP and GLP-1 concentrations
- Determinants of the Impaired Secretion of Glucagon-Like Peptide-1 in Type 2 Diabetic Patients
- Novel Insights into the Roles and Mechanisms of GLP-1 Receptor Agonists against Aging-Related Diseases
- Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
- GLP-1 Receptor Agonists Don't Raise Thyroid Cancer Risk
- Novel skeletal effects of glucagon-like peptide-1 (GLP-1) receptor agonists
- What Clinical Research Says About The Long-term Safety of Ozempic
- Many Patients Maintain Weight Loss a Year Af